HK1018782A1 - 2,3-benzodiazepine derivatives their preparation as well as the intermediates and their use as medicaments - Google Patents

2,3-benzodiazepine derivatives their preparation as well as the intermediates and their use as medicaments

Info

Publication number
HK1018782A1
HK1018782A1 HK99103802A HK99103802A HK1018782A1 HK 1018782 A1 HK1018782 A1 HK 1018782A1 HK 99103802 A HK99103802 A HK 99103802A HK 99103802 A HK99103802 A HK 99103802A HK 1018782 A1 HK1018782 A1 HK 1018782A1
Authority
HK
Hong Kong
Prior art keywords
medicaments
intermediates
preparation
well
benzodiazepine derivatives
Prior art date
Application number
HK99103802A
Other languages
English (en)
Inventor
Emese Csuzdi
Tamas Hamori
Gizella Abraham
Sandor Solyom
Istvan Tarnawa
Pal Berzsenyi
Ferenc Andrasi
Istvan Ling
Antal Simay
Melinda Gal
Katalin Horvath
Eszter Szentkuti
Marta Szollosy
Istvan Pallagi
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7785064&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1018782(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Ag filed Critical Schering Ag
Publication of HK1018782A1 publication Critical patent/HK1018782A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Addiction (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK99103802A 1996-02-01 1999-09-02 2,3-benzodiazepine derivatives their preparation as well as the intermediates and their use as medicaments HK1018782A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19604919A DE19604919A1 (de) 1996-02-01 1996-02-01 Neue 2,3-Benzodiazepinderivate, deren Herstellung und Verwendung als Arzneimittel
PCT/DE1997/000234 WO1997028163A1 (de) 1996-02-01 1997-01-29 Kondensierte 2,3-benzodiazepin derivate und deren verwendung als ampa-rezeptoren-hemmer

Publications (1)

Publication Number Publication Date
HK1018782A1 true HK1018782A1 (en) 2000-01-07

Family

ID=7785064

Family Applications (1)

Application Number Title Priority Date Filing Date
HK99103802A HK1018782A1 (en) 1996-02-01 1999-09-02 2,3-benzodiazepine derivatives their preparation as well as the intermediates and their use as medicaments

Country Status (31)

Country Link
US (2) US6323197B1 (ru)
EP (1) EP0888356B1 (ru)
JP (1) JP4141499B2 (ru)
KR (1) KR100465269B1 (ru)
CN (1) CN1096464C (ru)
AT (1) ATE214703T1 (ru)
AU (1) AU724956B2 (ru)
BG (1) BG63394B1 (ru)
BR (1) BR9707335A (ru)
CA (1) CA2245539C (ru)
CZ (1) CZ289658B6 (ru)
DE (2) DE19604919A1 (ru)
DK (1) DK0888356T3 (ru)
EE (1) EE04017B1 (ru)
ES (1) ES2173435T3 (ru)
HK (1) HK1018782A1 (ru)
HU (1) HU224636B1 (ru)
IL (1) IL125480A (ru)
IS (1) IS2103B (ru)
MY (1) MY119140A (ru)
NO (1) NO983510L (ru)
NZ (1) NZ331187A (ru)
PL (1) PL187128B1 (ru)
PT (1) PT888356E (ru)
RU (1) RU2179557C2 (ru)
SK (1) SK283563B6 (ru)
TR (1) TR199801485T2 (ru)
TW (1) TW438801B (ru)
UA (1) UA56157C2 (ru)
WO (1) WO1997028163A1 (ru)
ZA (1) ZA97848B (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP9701325A1 (hu) * 1997-07-31 2000-08-28 Gyógyszerkutató Intézet Kft. Új 2,3-benzodiazepin-származékok
UA67749C2 (ru) * 1997-08-12 2004-07-15 Егіш Дьйодьсердьяр Рт. Производные 8-замещенного-9н-1,3-диоксол/4,5-h//2,3/бензодиазепина, которые являются ингибиторами амра/каинитного рецептора
WO2000001376A2 (en) * 1998-07-02 2000-01-13 Eisai Co., Ltd Pharmaceutical compositions and their uses for treatment of demyelinating disorders
EP1296960A2 (en) * 2000-06-16 2003-04-02 Annovis, Inc. 5h-2,3-benzodiazepine antagonists of excitatory amino acid receptors
DE10041671C1 (de) * 2000-08-10 2002-06-13 Schering Ag Verfahren zur Herstellung von Imidazo[1,2-c][2,3]benzodiazepinen sowie Phenylessigsäureester und Oxazol-Derivate als Zwischenprodukte bei deren Herstellung
US20070280876A1 (en) * 2004-03-25 2007-12-06 William Marsh Rice University Functionalization of Carbon Nanotubes in Acidic Media
US20060166969A1 (en) * 2005-01-14 2006-07-27 Turski Lechoslaw A AMPA antagonists for the treatment of dizziness, including vertigo and Meniere's disorder
EP2338492A1 (en) 2009-12-24 2011-06-29 Universidad del Pais Vasco Methods and compositions for the treatment of alzheimer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5891871A (en) 1996-03-21 1999-04-06 Cocensys, Inc. Substituted 2,3-benzodiazepin-4-ones and the use thereof
HU9600871D0 (en) * 1996-04-04 1996-05-28 Gyogyszerkutato Intezet New 2,3-benzodiazepine derivatives

Also Published As

Publication number Publication date
CA2245539A1 (en) 1997-08-07
EE9800225A (et) 1998-12-15
US6323197B1 (en) 2001-11-27
IL125480A (en) 2002-07-25
BR9707335A (pt) 1999-07-20
CN1210538A (zh) 1999-03-10
UA56157C2 (ru) 2003-05-15
EP0888356B1 (de) 2002-03-20
EP0888356A1 (de) 1999-01-07
ATE214703T1 (de) 2002-04-15
JP2000503997A (ja) 2000-04-04
DK0888356T3 (da) 2002-06-03
CZ242798A3 (cs) 1999-01-13
NZ331187A (en) 2000-01-28
AU724956B2 (en) 2000-10-05
ES2173435T3 (es) 2002-10-16
NO983510L (no) 1998-09-30
DE19604919A1 (de) 1997-08-07
NO983510D0 (no) 1998-07-30
ZA97848B (en) 1997-08-04
HU224636B1 (hu) 2005-12-28
IS4794A (is) 1998-07-06
US6600036B2 (en) 2003-07-29
PL328224A1 (en) 1999-01-18
DE59706686D1 (de) 2002-04-25
IL125480A0 (en) 1999-03-12
CN1096464C (zh) 2002-12-18
HUP9901417A3 (en) 2001-11-28
US20020052364A1 (en) 2002-05-02
TW438801B (en) 2001-06-07
PT888356E (pt) 2002-09-30
RU2179557C2 (ru) 2002-02-20
IS2103B (is) 2006-05-15
MY119140A (en) 2005-04-30
TR199801485T2 (xx) 1998-10-21
SK103398A3 (en) 1999-01-11
HUP9901417A2 (hu) 1999-08-30
SK283563B6 (sk) 2003-09-11
JP4141499B2 (ja) 2008-08-27
AU2502997A (en) 1997-08-22
BG102658A (en) 1999-06-30
PL187128B1 (pl) 2004-05-31
WO1997028163A1 (de) 1997-08-07
CZ289658B6 (cs) 2002-03-13
CA2245539C (en) 2005-10-04
KR100465269B1 (ko) 2005-04-14
BG63394B1 (bg) 2001-12-29
KR19990082192A (ko) 1999-11-25
EE04017B1 (et) 2003-04-15

Similar Documents

Publication Publication Date Title
HUP0105414A2 (hu) Pirrolo-izokinolin-, azepino- és diazepino-indol-származékok, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények
BG104561A (en) Aryl fused azapolycyclic compounds
HUP9802927A2 (hu) Alfa2-receptorokra ható imidazol-származékok, e vegyületeket tartalmazó gyógyászati készítmények és alkalmazásuk
MXPA02011417A (es) 1-aminoalquil-lactamas sustituidas y su uso como antagonistas de receptores muscarinicos.
MX9806171A (es) Derivados 2,3-benzodiazepina y sus usos como inhibidores del receptor-ampa.
SE9702564D0 (sv) New compounds
HUP0004477A2 (hu) Herbicid hatású 3-(1,2-benzizotiazol- vagy-izoxazol-5-il)-csoporttal helyettesített pirimidinszármazékok, intermedierjeik, előállításuk és alkalmazásuk
TW429255B (en) Pyrazine compounds having treatment of central nervous system diseases and disorders
HK1018782A1 (en) 2,3-benzodiazepine derivatives their preparation as well as the intermediates and their use as medicaments
YU64400A (sh) Aril fuzirana azapoliciklična jedinjenja
ES8504731A1 (es) Un procedimiento para preparar antra 1,9-cd-7pirazol-6(2h)-onas
BG102618A (en) Derivatives of 5h, 1oh-imidazo[1,2-a)inden[1,2-e]pyrazin-4-on, their preparation and their intermediate products and medicaments containing them
ATE56713T1 (de) 1,2,3,4,4a,9b-hexahydro-4aaminoalkyldibenzofurane, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ES2173167T3 (es) Derivados de benzodiazepina.
ES8506716A1 (es) Un metodo de preparar espiro (indolo (1, 7-ab) (1, 5)-benzodiazepin-2, 4'-piperidinas)
MY105852A (en) New 2-methoxycarbonyl substituted n, n'' -di- (trimethoxybenzoyl) piperazines, process for preparing the same and therapeutical compounds containing them.
MY104554A (en) Benzofuran derivatives.
ES2058761T3 (es) Proceso para la preparacion de derivados de dibenzodioxazecina y dibenzodioxaazacicloundecina.

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20130129